Ariel, Israel

Yosi Gilad

This inventor holds 1 USPTO granted patent. Top assignee: Ariel Scientific Innovations Ltd.. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yosi Gilad. Retrieved from https://idiyas.com/inventor/yosi-gilad

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yosi Gilad: Innovator in Anticancer Drug Conjugates

Introduction

Yosi Gilad is a notable inventor based in Ariel, Israel. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anticancer therapies. His innovative approach focuses on creating drug conjugates that enhance the efficacy of cancer treatment.

Latest Patents

Yosi Gilad holds a patent for anticancer drug conjugates. The patent describes a conjugate comprising two residues of structurally and/or mechanistically different anticancer bioactive agents, coupled to one another by a biocleavable linking moiety. This invention also includes methods of treating cancer using these conjugates and pharmaceutical compositions that incorporate them. He has 1 patent to his name.

Career Highlights

Yosi Gilad is associated with Ariel Scientific Innovations Ltd., where he continues to work on groundbreaking research in the field of cancer treatment. His dedication to innovation has positioned him as a key figure in the pharmaceutical industry.

Collaborations

Yosi collaborates with talented individuals such as Gary Gellerman and Helena Tuchinsky, who contribute to his research efforts and the advancement of their projects.

Conclusion

Yosi Gilad's work in developing anticancer drug conjugates showcases his commitment to improving cancer treatment options. His innovative contributions are paving the way for future advancements in the pharmaceutical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…